Skip to content

OraSure Technologies OSUR Other Nonoperating Income

Other Nonoperating Income at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$27.9M-6.7%
Gross profit$11.8M-4.0%
Operating income-$23.3M-31.1%
Net income-$22.4M-39.5%
EPS (diluted)-$0.32-52.4%

Balance sheet

See full
Cash & equivalents$177.0M-28.5%
Total debt$12.7M-10.9%
Total equity$313.3M-20.9%
Total assets$379.2M-17.1%

Cash flow

See full
Operating cash flow-$13.9M+29.6%
CapEx$913.0K+117%
Free cash flow-$14.8M+26.5%

Valuation

See full
Market cap$303.62M+35.3%
Enterprise value$139.32M-1,654%
P/S2.7×+1.3×

Profitability

See full
Gross margin42.2%+0.4pp
Operating margin-68.6%-149pp
Net margin-66.4%-115pp
FCF margin-42.4%-43.3pp

Returns & leverage

See full
Return on equity-21.2%-50.4pp
Debt / equity0.0×
Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncome.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's other nonoperating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OraSure Technologies's other nonoperating income?
OraSure Technologies (OSUR) reported other nonoperating income of $1.55M in Q1 2026.
How has OraSure Technologies's other nonoperating income changed year-over-year?
OraSure Technologies's other nonoperating income decreased by 12.9% year-over-year, from $1.78M to $1.55M.
What is the long-term trend for OraSure Technologies's other nonoperating income?
Over 3 years (2022 to 2025), OraSure Technologies's other nonoperating income has grown at a 4.4% compound annual growth rate (CAGR), from $6.48M to $7.38M.
What does other nonoperating income mean?
This metric captures income generated from activities outside of the company's core diagnostic and molecular solutions operations, such as interest income, foreign exchange gains, or miscellaneous financial receipts. It provides insight into the company's ability to generate supplemental cash flows independent of its primary product sales. Monitoring this helps investors distinguish between core business performance and peripheral financial gains.